CJ28 is a cortisol biosynthesis inhibitor. In human adrenocortical carcinoma cell models, it significantly reduces cortisol production under both basal and stimulated conditions. The mechanism of action of CJ28 is primarily associated with the inhibition of the steroidogenesis pathway and de novo cholesterol biosynthesis, thereby reducing the supply of cortisol precursors and downregulating hormone synthesis levels.
Molecular Weight:
331.17
Purity:
99.34%
CAS Number:
[3047118-54-4]
Formula:
C14H11BrN4O
Target:
Endogenous Metabolite
TN11148
* VAT and and shipping costs not included. Errors and price changes excepted
